Guardant Health, Inc. (GH): Total Liabilities
$2.11B
As of 2025-12-31
$2.14B
As of 2026-06-30
+10.9%
3-year compound annual growth
+18.2%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.11B | +30.0% | 2026-02-19, Balance as of period end |
| 2024-12-31 | $1.63B | -0.2% | 2026-02-19, Balance as of period end |
| 2023-12-31 | $1.63B | +5.0% | 2025-02-20, Balance as of period end |
| 2022-12-31 | $1.55B | -0.6% | 2024-02-22, Balance as of period end |
| 2021-12-31 | $1.56B | +70.2% | 2023-02-23, Balance as of period end |
| 2020-12-31 | $916.19M | +699.9% | 2022-02-24, Balance as of period end |
| 2019-12-31 | $114.54M | +83.4% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $62.45M | +81.9% | 2020-03-02, Balance as of period end |
| 2017-12-31 | $34.33M | n/a | 2019-03-19, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Guardant Health, Inc. (GH) | 2025-12-31 | $2.11B | +30.0% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $548.36M | -11.7% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $96.44M | -22.3% |
| RadNet, Inc. (RDNT) | 2025-12-31 | $2.40B | +11.6% |
| Natera, Inc. (NTRA) | 2025-12-31 | $685.93M | +47.4% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $110.13M | -2.2% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $2.15B | -2.9% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $107.68M | +42.8% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $106.81M | +17.6% |
Compare GH, CAI, VCYT, RDNT side by side · Screen every company in Services-Medical Laboratories ↗